NCT05904275

Brief Summary

Lumbosacral spine surgeries are commonly performed under GA. Perioperative pain following spine surgeries not only contributes to significant morbidities but also hampers early mobilization. Perioperative opioids, though relieve pain but hampers consciousness, increase PONV and delays mobilization. Caudal analgesia can be effectively given preemptively to alleviate pain and facilitate early mobilization. Caudal epidural block places the needle through the sacral hiatus into the epidural space to deliver medications. It can be performed as ultrasound guided procedure with very high successful rates. Single shot caudal block with local anesthetic provides analgesia for 2-4 hours but this can be further prolonged by adding adjuvants like opioids, steroids, ketamine, alpha 2 agonists, adrenaline etc. Ropivacaine is a long-acting amide local anesthetic agent which is less lipophilic, less cardiac and central nervous system toxicity with similar duration of analgesia, has lesser motor blockade and facilitates earlier mobilization than bupivacaine. Dexamethasone is a highly potent, long acting glucocorticoid. Caudal dexamethasone prolongs the analgesic duration of the ropivacaine. The aim of this study is to evaluate the role of pre-emptive caudal epidural analgesia for postoperative pain relief in lumbosacral surgeries and to compare the effect of adding dexamethasone to ropivacaine with respect to quality of analgesia, duration of analgesia, hemodynamic effects and associated side effects.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

7 months

First QC Date

January 27, 2023

Last Update Submit

June 13, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Visual Analogue Scale score

    postoperative Visual Analogue Scale score

    At immediate postoperative period

  • Visual Analogue Scale score

    postoperative Visual Analogue Scale score

    At 4 hours postoperatively

  • Visual Analogue Scale score

    postoperative Visual Analogue Scale score

    At 8 hours postoperatively

  • Visual Analogue Scale score

    postoperative Visual Analogue Scale score

    At 12 hours postoperatively

  • Visual Analogue Scale score

    postoperative Visual Analogue Scale score

    At 24 hours postoperatively

  • Time of rescue analgesia

    Time of VAS score \>4 asking for rescue analgesia

    24 hours

Study Arms (2)

Group RD

EXPERIMENTAL

Group RD - caudal epidural injection with 0.25% ropivacaine 20 ml containing dexamethasone 8 mg (0.5% Ropivacaine 10 ml + 8 mg/2 ml Dexamethasone + 8 ml NS)

Drug: caudal epidural injection

Group R

EXPERIMENTAL

Group R- caudal epidural injection with 0.25% ropivacaine 20 ml

Drug: caudal epidural injection

Interventions

Preoperative Ultrasound guided caudal epidural injection in lumbosacral spine surgeries for postoperative analgesia.

Also known as: Caudal epidural injection with ropivacaine and dexamethasone
Group RGroup RD

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing lumbosacral spine surgeries by posterior approach, including discectomy, laminectomy and laminotomy with or without instrumentation
  • ASA PS I and II
  • Age 18 to 65 years

You may not qualify if:

  • Patients with hypersensitivity to ropivacaine.
  • Patients with anomalies of sacral anatomy.
  • Local site infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (17)

  • Weinstein JN, Lurie JD, Olson PR, Bronner KK, Fisher ES. United States' trends and regional variations in lumbar spine surgery: 1992-2003. Spine (Phila Pa 1976). 2006 Nov 1;31(23):2707-14. doi: 10.1097/01.brs.0000248132.15231.fe.

    PMID: 17077740BACKGROUND
  • Meng T, Zhong Z, Meng L. Impact of spinal anaesthesia vs. general anaesthesia on peri-operative outcome in lumbar spine surgery: a systematic review and meta-analysis of randomised, controlled trials. Anaesthesia. 2017 Mar;72(3):391-401. doi: 10.1111/anae.13702. Epub 2016 Oct 22.

    PMID: 27770448BACKGROUND
  • Kao SC, Lin CS. Caudal Epidural Block: An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:9217145. doi: 10.1155/2017/9217145. Epub 2017 Feb 26.

    PMID: 28337460BACKGROUND
  • Klocke R, Jenkinson T, Glew D. Sonographically guided caudal epidural steroid injections. J Ultrasound Med. 2003 Nov;22(11):1229-32. doi: 10.7863/jum.2003.22.11.1229.

    PMID: 14620894BACKGROUND
  • Chen CP, Wong AM, Hsu CC, Tsai WC, Chang CN, Lin SC, Huang YC, Chang CH, Tang SF. Ultrasound as a screening tool for proceeding with caudal epidural injections. Arch Phys Med Rehabil. 2010 Mar;91(3):358-63. doi: 10.1016/j.apmr.2009.11.019.

    PMID: 20298824BACKGROUND
  • Nikooseresht M, Hashemi M, Mohajerani SA, Shahandeh F, Agah M. Ultrasound as a screening tool for performing caudal epidural injections. Iran J Radiol. 2014 May;11(2):e13262. doi: 10.5812/iranjradiol.13262. Epub 2014 May 15.

    PMID: 25035698BACKGROUND
  • Chen CP, Tang SF, Hsu TC, Tsai WC, Liu HP, Chen MJ, Date E, Lew HL. Ultrasound guidance in caudal epidural needle placement. Anesthesiology. 2004 Jul;101(1):181-4. doi: 10.1097/00000542-200407000-00028.

    PMID: 15220789BACKGROUND
  • Blanchais A, Le Goff B, Guillot P, Berthelot JM, Glemarec J, Maugars Y. Feasibility and safety of ultrasound-guided caudal epidural glucocorticoid injections. Joint Bone Spine. 2010 Oct;77(5):440-4. doi: 10.1016/j.jbspin.2010.04.016. Epub 2010 Sep 24.

    PMID: 20869897BACKGROUND
  • Yoon JS, Sim KH, Kim SJ, Kim WS, Koh SB, Kim BJ. The feasibility of color Doppler ultrasonography for caudal epidural steroid injection. Pain. 2005 Nov;118(1-2):210-4. doi: 10.1016/j.pain.2005.08.014. Epub 2005 Oct 4.

    PMID: 16213088BACKGROUND
  • Aggarwal A, Aggarwal A, Harjeet, Sahni D. Morphometry of sacral hiatus and its clinical relevance in caudal epidural block. Surg Radiol Anat. 2009 Dec;31(10):793-800. doi: 10.1007/s00276-009-0529-4. Epub 2009 Jul 4.

    PMID: 19578805BACKGROUND
  • Kiribayashi M, Inagaki Y, Nishimura Y, Yamasaki K, Takahashi S, Ueda K. Caudal blockade shortens the time to walking exercise in elderly patients following low back surgery. J Anesth. 2010 Apr;24(2):192-6. doi: 10.1007/s00540-009-0840-6. Epub 2010 Jan 19.

    PMID: 20084409BACKGROUND
  • Kumar S, Palaniappan JM, Kishan A. Preemptive Caudal Ropivacaine: An Effective Analgesic during Degenerative Lumbar Spine Surgery. Asian Spine J. 2017 Feb;11(1):113-119. doi: 10.4184/asj.2017.11.1.113. Epub 2017 Feb 17.

    PMID: 28243379BACKGROUND
  • Kalappa S, Sridhara RB, Kumaraswamy S. Dexmedetomidine as an Adjuvant to Pre-Emptive Caudal Epidural Ropivacaine for Lumbosacral Spine Surgeries. J Clin Diagn Res. 2016 Jan;10(1):UC22-4. doi: 10.7860/JCDR/2016/15286.7145. Epub 2016 Jan 1.

    PMID: 26894155BACKGROUND
  • Samagh N, Pai RK, Mathews TK, Jangra K, Varma RG. Pre-emptive caudal epidural analgesia with ropivacaine for lumbosacral spine surgery: A randomized case control study. J Anaesthesiol Clin Pharmacol. 2018 Apr-Jun;34(2):237-241. doi: 10.4103/joacp.JOACP_72_17.

    PMID: 30104836BACKGROUND
  • Rosenberg PH, Heinonen E. Differential sensitivity of A and C nerve fibres to long-acting amide local anaesthetics. Br J Anaesth. 1983 Feb;55(2):163-7. doi: 10.1093/bja/55.2.163.

    PMID: 6830678BACKGROUND
  • Kalappa S, Sridhar RB, Nagappa S. Comparing the Efficacy of Caudal with Intravenous Dexamethasone in the Management of Pain Following Lumbosacral Spine Surgeries: A Randomized Double Blinded Controlled Study. Anesth Essays Res. 2017 Apr-Jun;11(2):416-420. doi: 10.4103/0259-1162.194581.

    PMID: 28663633BACKGROUND
  • Baliga S, Treon K, Craig NJ. Low Back Pain: Current Surgical Approaches. Asian Spine J. 2015 Aug;9(4):645-57. doi: 10.4184/asj.2015.9.4.645. Epub 2015 Jul 28.

MeSH Terms

Conditions

Pain, Postoperative

Interventions

RopivacaineDexamethasone

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Officials

  • Jay Pr Thakur, MD,FIPM

    National Academy of Medical Science, Nepal

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jay Pr Thakur, MD, FIPM

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

January 27, 2023

First Posted

June 15, 2023

Study Start

August 1, 2023

Primary Completion

February 28, 2024

Study Completion

February 28, 2024

Last Updated

June 15, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share